Brendan P. Eckelman, Chief Scientific Officer, 10% Owner at Inhibrx, Inc. (INBX), sold 17,000 shares at $19.02 ($323K) on 2021-03-24, disclosed to the SEC on 2021-03-24.
Open-market sale of $323k INBX by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INBX | SELL | 2022-12-07 | $2.1M | — | Filing → |
| INBX | SELL | 2022-11-02 | $2.7M | — | Filing → |
| INBX | SELL | 2022-10-05 | $2.2M | — | Filing → |